Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00968825
Recruitment Status : Completed
First Posted : August 31, 2009
Last Update Posted : November 19, 2013
Information provided by (Responsible Party):
Revance Therapeutics, Inc.

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : October 2009
  Actual Study Completion Date : October 2009
  Certification/Extension First Submitted : June 13, 2011